John Beary III

John Beary III

Professor of Clinical Aff

Veterans Admin Med Ctr

COM IM Immunology Division - 0563

Health Professions Building
3255 Eden Avenue
Cincinnati, Ohio 45267-0563

Education

Master's Degree, Georgetown University 1988 (Business Administration )

Medical Degree, Harvard Medical School 1973

Internship, Johns Hopkins Hospital 1974 (Osler Medical Service)

Residency , Johns Hopkins Hospital 1978 (Osler Medical Service)

Fellowship, Rheumatology Hospital for Special Surgery 1980 (Research )

Positions and Work Experience

2009 -To Present Attending Physician (Rheumatology Section, Cincinnati VAMC) and Volunteer Professor of Medicine (Division of Immunology and Rheumatology, University of Cincinnati), Cincinnati, OH

1997 -2008 Senior Medical Director, Musculoskeletal and Bone Research, Department of Worsldwide Clinical Development, Procter & Gamble Pharmaceuticals, Cincinnati, OH

1988 -1997 Senior Vice President for Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, DC

1984 -1987 Associate Dean for Strategic Planning, Georgetown University School of Medicine,

1981 -1983 Deputy Assistant Secretary of Defense (Health Affairs), Department of Defense, Washington, DC

1980 -1981 Assistant Professor of Medicine, Georgetown University School of Medicine,

Research and Practice Interests

Clinical trials, Clinical Pharamcology, Drug Utiliztion, Verteran's Health Outcomes, Osteoarthritis, Rheumatoid Arthritis.

Publications

Peer Reviewed Publications

Katyal, Nakul; George, Pravin; Nattanamai, Premkumar; Raber, Larry N; Beary, Jonathan M; Newey, Christopher R (2018. ) Improvement in Sonographic Vasospasm Following Intravenous Milrinone in a Subarachnoid Hemorrhage Patient with Normal Cardiac Function.Cureus, , 10 (7 ) ,e2916

Katyal, Nakul; Narula, Naureen; George, Pravin; Nattanamai, Premkumar; Newey, Christopher R; Beary, Jonathan M (2018. ) Delayed Post-hypoxic Leukoencephalopathy: A Case Series and Review of the Literature.Cureus, , 10 (4 ) ,e2481

Katyal, Nakul; Taqui, Ather M; Tepper, Deborah; Beary, Jonathan M; Newey, Christopher R (2018. ) Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy.Cureus, , 10 (4 ) ,e2467

Katyal, Nakul; Newey, Christopher R; George, Pravin; Nattanamai, Premkumar; Beary, Jonathan M; Ardelt, Agnieszka; Vellipuram, Anantha (2018. ) Somatosensory Evoked Potentials as a Tool to Evaluate Brainstem Herniation in the Neuroscience Intensive Care Unit.Cureus, , 10 (4 ) ,e2443

Mullaguri, Naresh; Katyal, Nakul; Sarwal, Aarti; Beary, Jonathan M; George, Pravin; Karthikeyan, Naresh; Nattanamai, Premkumar; Newey, Christopher R (2017. ) Pitfall in Pupillometry: Exaggerated Ciliospinal Reflex in a Patient in Barbiturate Coma Mimicking a Nonreactive Pupil.Cureus, , 9 (12 ) ,e2004

McClung, M R; Zanchetta, J R; Racewicz, A; Roux, C; Benhamou, C-L; Man, Z; Eusebio, R A; Beary, J F; Burgio, D E; Matzkin, E; Boonen, S; Delmas, P (2013. ) Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, , 24 (1 ) ,293-9

Ste-Marie, Louis-Georges; Brown, Jacques P; Beary, John F; Matzkin, Ellen; Darbie, Lynn M; Burgio, David E; Racewicz, Artur J (2009. ) Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.Clinical therapeutics, , 31 (2 ) ,272-85

Garnero, P; Aronstein, W S; Cohen, S B; Conaghan, P G; Cline, G A; Christiansen, C; Beary, J F; Meyer, J M; Bingham, C O (2008. ) Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.Osteoarthritis and cartilage, , 16 (6 ) ,660-6

Raynauld, J-P; Martel-Pelletier, J; Berthiaume, M-J; Abram, F; Choquette, D; Haraoui, B; Beary, J F; Cline, G A; Meyer, J M; Pelletier, J-P (2008. ) Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.Annals of the rheumatic diseases, , 67 (5 ) ,683-8

Delmas, Pierre D; McClung, Michael R; Zanchetta, José R; Racewicz, Artur; Roux, Christian; Benhamou, Claude-Laurent; Man, Zulema; Eusebio, Rachelle A; Beary, John F; Burgio, David E; Matzkin, Ellen; Boonen, Steven (2008. ) Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.Bone, , 42 (1 ) ,36-42

Krzeski, Piotr; Buckland-Wright, Chris; Bálint, Géza; Cline, Gary A; Stoner, Karen; Lyon, Robert; Beary, John; Aronstein, William S; Spector, Tim D (2007. ) Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.Arthritis research & therapy, , 9 (5 ) ,R109

Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Berthiaume, Marie-Josée; Abram, François; Choquette, Denis; Haraoui, Boulos; Beary, John F; Cline, Gary A; Meyer, Joan M; Martel-Pelletier, Johanne (2007. ) Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.Arthritis research & therapy, , 9 (4 ) ,R74

Bingham, Clifton O; Buckland-Wright, J Chris; Garnero, Patrick; Cohen, Stanley B; Dougados, Maxime; Adami, Silvano; Clauw, Daniel J; Spector, Timothy D; Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Strand, Vibeke; Simon, Lee S; Meyer, Joan M; Cline, Gary A; Beary, John F (2006. ) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.Arthritis and rheumatism, , 54 (11 ) ,3494-507

Beary, John F (2006. ) Food and Drug Administration centennial: recognizing the guardians of our drug supply.Arthritis and rheumatism, , 54 (10 ) ,3374

O'Connor, Annette M; McKean, James D; Beary, John H; Brockus, Susan L (2006. ) Prevalence of exposure to Salmonella spp in finishing swine marketed in Iowa.American journal of veterinary research, , 67 (5 ) ,829-33

Raynauld, Jean-Pierre; Martel-Pelletier, Johanne; Berthiaume, Marie-Josée; Beaudoin, Gilles; Choquette, Denis; Haraoui, Boulos; Tannenbaum, Hyman; Meyer, Joan M; Beary, John F; Cline, Gary A; Pelletier, Jean-Pierre (2006. ) Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.Arthritis research & therapy, , 8 (1 ) ,R21

Cline, G A; Meyer, J M; Stevens, R; Buckland-Wright, C; Peterfy, C; Beary, John F (2006. ) Comparison of fixed flexion, fluoroscopic semi-flexed and MTP radiographic methods for obtaining the minimum medial joint space width of the knee in longitudinal osteoarthritis trials.Osteoarthritis and cartilage, , 14 Suppl A ,A32-6

Spector, Tim D; Conaghan, Philip G; Buckland-Wright, J Christopher; Garnero, Patrick; Cline, Gary A; Beary, John F; Valent, David J; Meyer, Joan M (2005. ) Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].Arthritis research & therapy, , 7 (3 ) ,R625-33

Beary, J F (2001. ) Joint structure modification in osteoarthritis: development of SMOAD drugs.Current rheumatology reports, , 3 (6 ) ,506-12

Beary, J F (1996. ) Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view.Journal of general internal medicine, , 11 (10 ) ,635-6

Beary, J F (1995. ) Inappropriate drug prescribing.JAMA, , 273 (6 ) ,455-6; author reply

Beary, J F (1994. ) The CERT concept: an industry perspective.Clinical pharmacology and therapeutics, , 56 (6 Pt 1 ) ,693-7

Beary, J F; Eaton, C R; Wierenga, D E (1993. ) Basic research and the cost of health care.Science (New York, N.Y.), , 262 (5138 ) ,1358

Beary, J F (1992. ) Pharmaceutical ads in journals. Annals of internal medicine, , 117 (7 ) ,616; author reply 61

Beary, J F; Eaton, C R (1992. ) Chirality and drug development.Science (New York, N.Y.), , 257 (5067 ) ,145

Beary, J F; Cleveland, C B (1992. ) DPS--the PMA perspective. American pharmacy, , NS32 (5 ) ,6, 8

Beary, J F (1992. ) Chirality and drug development.Lancet (London, England), , 339 (8791 ) ,495

Beary, J F (1990. ) New drug and biologic product approvals in 1989.Southern medical journal, , 83 (11 ) ,1289-94

Beary, J F (1990. ) Geriatric medications in the pipeline.Health affairs (Project Hope), , 9 (3 ) ,157-60

Beary, J F (1989. ) New drug approvals in 1988.Southern medical journal, , 82 (8 ) ,995-8

Brett, A S; Phillips, M; Beary, J F (1986. ) Predictive power of the polygraph: can the "lie detector" really detect liars?.Lancet (London, England), , 1 (8480 ) ,544-7

Beary, J F (1986. ) The polygraph: does it really detect lies? .American family physician, , 33 (3 ) ,98, 100

White, K B; Beary, J F (1986. ) Illegible handwritten medical records.The New England journal of medicine, , 314 (6 ) ,390-1

D'Angelo, L J; Beary, J F; Stair, T (1984. ) Tetanus mimicking "pseudotetanus".Southern medical journal, , 77 (8 ) ,1052-3

Beary, J F; Walter, L J; Johns, J H (1984. ) Leading causes of death for active duty military personnel. Military medicine, , 149 (6 ) ,316-7

Beary, J F (1984. ) Strategic planning: military medicine in the eighties. Military medicine, , 149 (4 ) ,181-3

Beary, J F (1983. ) Federal medical chiefs on progress and planning. Department of Defense. Military medicine, , 148 (11 ) ,857-63

Armstrong, P C; Beary, J F (1983. ) Office of the Assistant Secretary of Defense for Health Affairs: a history. Military medicine, , 148 (8 ) ,637-43

Nazzaro, J T; Beary, J F (1983. ) Benefits of a computerized pharmacy.JAMA, , 249 (24 ) ,3302-3

Beary, J F (1983. ) Medical readiness DoD's main goal. U. S. medicine, , 19 (2 ) ,9-12

Beary, J F (1982. ) Federal Medical Chiefs on progress and plans. Department of defense. Military medicine, , 147 (11 ) ,943-8

Beary, J F; Bisgard, J C; Armstrong, P C (1982. ) The Civilian-Military Contingency Hospital System.The New England journal of medicine, , 306 (12 ) ,738-40

Kimberly, R P; Lockshin, M D; Sherman, R L; Beary, J F; Mouradian, J; Cheigh, J S (1981. ) "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine, , 60 (4 ) ,277-87

Beary, J; Gilbert, S (1981. ) Coping with the "bashful bladder" syndrome.Lancet (London, England), , 1 (8235 ) ,1429-30

Beary, J F (1979. ) Mercury in sperm whale meat.Science (New York, N.Y.), , 206 (4424 ) ,1260

Beary, J F (1979. ) Gout: diagnosis and therapy. ONA journal, , 6 (8 ) ,313-7

Beary, J F; Summer, W R; Bulkley, B H (1979. ) Postpartum acute myocardial infarction: a rare occurrence of uncertain etiology.The American journal of cardiology, , 43 (1 ) ,158-61

Beary, J F (1978. ) Tobacco subsidies.The New England journal of medicine, , 298 (13 ) ,749

Beary, J F (1978. ) Pediatric injury and the steel jaw trap.JAMA, , 239 (10 ) ,931

Beary, J F (1977. ) Pseudoephedrine producing postural hypotension in a pilot. Aviation, space, and environmental medicine, , 48 (4 ) ,369

Beary, J F; Fortuin, N J (1974. ) Practolol for sinus tachycardia in asthma.Annals of internal medicine, , 81 (3 ) ,405

Beary, J F; Benson, H A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response.Psychosomatic medicine, , 36 (2 ) ,115-20

Benson, H; Beary, J F; Carol, M P (1974. ) The relaxation response.Psychiatry, , 37 (1 ) ,37-46

Beary J.;Siegfried J.;Tavares R. (10-14-1998. ) US drug and biologic approvals in 1997.Drug Development Research, , 44 (2-3 ) ,114-129

Beary J.;Robillard L.;Woollett G.;Siegfried J.;White T.;Shriver D. (04-01-1997. ) U.S. drug and biological approvals in 1996.Drug Development Research, , 40 (4 ) ,275-291

Beary J.;Duchaine C.;Rhein R. (04-01-1996. ) U.S. Drug and biologic approvals in 1994-1995.Drug Development Research, , 37 (4 ) ,197-207

Beary J. (01-01-1994. ) In Reply: More Conflicts of Interest: Review Articles Sponsored by the Pharmaceutical Industry.JAMA: The Journal of the American Medical Association, , 272 (16 ) ,1254

Beary J.;Robert Eaton C.;Copmann T.;Wierenga D. (01-01-1994. ) U.S. drug and biologic product approvals during 1993.Drug Development Research, , 32 (3 ) ,127-133

Beary J.;Eaton C.;Copmann T.;Wierenga D. (12-20-1993. ) USA drug and biologic product approvals during 1992 .Journal of Pharmaceutical Medicine, , 3 (2 ) ,101-109

Beary J.;Wierenga D.;Copmann T. (01-01-1992. ) USA drug and biological product approvals during 1990 .Journal of Pharmaceutical Medicine, , 2 (1 ) ,59-65

Beary J.;Wierenga D.;Copmann T.;Eaton C. (01-01-1992. ) USA drug and biologic product approvals during 1991 .Journal of Pharmaceutical Medicine, , 2 (3 ) ,175-182

Beary J.;Angel J.;Liebman M.;Lexchin J.;Noble R.;Agzarian A.;Krinsky D.;Wilkes M.;Doblin B.;Shapiro M. (01-01-1992. ) Pharmaceutical ads in journals [1].Annals of Internal Medicine, , 117 (7 ) ,616-619

Huseby J.;Anderson P.;Beary J. (08-22-1991. ) Confusion about Drug Names.New England Journal of Medicine, , 325 (8 ) ,588-589

Beary J. (01-01-1990. ) Directions in research for Alzheimer's treatments .Hospital Pharmacy, , 25 (6 ) ,593-594

Honors and Awards

2003 Vicennial Service Award Georgetown University

1997 Lifetime Achievement Award American Academy of Pharmaceutical Physicians

2001 Honorary Member 6th Naval Beach Battalion (D-Day)

1997 Navy & Marine Corps Commendation Medal

1991 National Defense Service Medal (Navy)

1984 -To Present Who's Who in America

1983 Distinguished Public Service Medal Department of Defense

1979 New York Arthiritis Foundation Research Award

Post Graduate Training and Education

1973-1974 Intern, Osler Medical Service, Johns Hopkins Hospital, , Maryland, MD

1977-1978 Resident, Osler Medical Service, Johns Hopkins Hospital, , Baltimore, MD

1978-1980 Research Fellow, Rheumatology, Hospital for Special Surgery, , New York, NY

Keywords

Rheumatologist; clinical pharmacologist; veterans administration

Contact Information

Academic - Health Professions Building
3255 Eden Avenue
Cincinnati  Ohio, 45267-0563
Phone: 513-558-4701
Fax: 513-558-3799
john.beary@uc.edu